Red Fluorescent Zinc Oxide Nanoparticle: a Novel Platform for Cancer Targeting.

Hao Hong,Fei Wang,Yin Zhang,Stephen A. Graves,Savo Bou Zein Eddine,Yunan Yang,Charles P. Theuer,Robert J. Nickles,Xudong Wang,Weibo Cai
DOI: https://doi.org/10.1021/am508440j
IF: 9.5
2015-01-01
ACS Applied Materials & Interfaces
Abstract:Multifunctional zinc oxide (ZnO) nanoparticles (NPs) with well-integrated multimodality imaging capacities have generated increasing research interest in the past decade. However, limited progress has been made in developing ZnO NP-based multimodality tumor-imaging agents. Here we developed novel red fluorescent ZnO NPs and described the successful conjugation of 64Cu (t1/2=12.7 h) and TRC105, a chimeric monoclonal antibody against CD105, to these ZnO NPs via well-developed surface engineering procedures. The produced dual-modality ZnO NPs were readily applicable for positron emission tomography (PET) imaging and fluorescence imaging of the tumor vasculature. Their pharmacokinetics and tumor-targeting efficacy/specificity in mice bearing murine breast 4T1 tumor were thoroughly investigated. ZnO NPs with dual-modality imaging properties can serve as an attractive candidate for future cancer theranostics.
What problem does this paper attempt to address?